(ALIT) Alight - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US01626W1018

Platform, Benefits, Healthcare, Wellbeing, AI

Dividends

Dividend Yield 7.58%
Yield on Cost 5y 1.47%
Yield CAGR 5y 0.00%
Payout Consistency 100.0%
Payout Ratio 37.2%
Risk via 5d forecast
Volatility 41.1%
Value at Risk 5%th 57.6%
Relative Tail Risk -14.96%
Reward TTM
Sharpe Ratio -2.42
Alpha -88.83
CAGR/Max DD -0.44
Character TTM
Hurst Exponent 0.559
Beta 1.411
Beta Downside 1.432
Drawdowns 3y
Max DD 80.46%
Mean DD 29.15%
Median DD 28.20%

Description: ALIT Alight November 08, 2025

Alight, Inc. (NYSE: ALIT) is a Chicago-based, technology-enabled services firm that delivers the Alight Worklife platform-a cloud-native suite for employee engagement covering benefits administration, healthcare navigation, financial wellbeing, leave-of-absence management, retiree health, and AI-driven analytics. The company also operates a full-service customer-care center to manage the end-to-end lifecycle of health, wealth, and wellbeing for corporate clients. Founded in 2020, Alight positions itself within the Human Resource & Employment Services sub-industry.

Key metrics and sector drivers (as of FY 2023): • Revenue of approximately $2.2 billion, up ~12 % YoY, reflecting strong demand for integrated benefits solutions amid rising employer spending on health and wellness programs. • Operating margin hovered around 6 % after a 2022 integration of HIG Capital’s H&R Block Benefits business, indicating modest profitability but also highlighting cost-structure sensitivity. • Client concentration remains a risk, with the top 10 customers accounting for roughly 30 % of revenue, a common pattern in the B2B HR services space. • Macro-level drivers include tightening labor markets, increasing regulatory scrutiny on benefits compliance, and accelerated adoption of AI for personalized employee experiences-all of which could expand the addressable market for Alight’s platform.

If you’re looking to deepen your analysis, ValueRay’s data suite offers granular, real-time insights on ALIT’s financial health and competitive positioning that can help you assess the stock’s risk-adjusted upside.

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (-2.16b TTM) > 0 and > 6% of Revenue (6% = 137.3m TTM)
FCFTA 0.04 (>2.0%) and ΔFCFTA 2.54pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 7.73% (prev 10.53%; Δ -2.80pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.06 (>3.0%) and CFO 354.0m > Net Income -2.16b (YES >=105%, WARN >=100%)
NO Net Debt/EBITDA fails (EBITDA <= 0)
Current Ratio 1.21 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (528.5m) change vs 12m ago -1.37% (target <= -2.0% for YES)
Gross Margin 36.00% (prev 34.15%; Δ 1.85pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 33.15% (prev 31.58%; Δ 1.57pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio -20.57 (EBITDA TTM -1.40b / Interest Expense TTM 88.0m) >= 6 (WARN >= 3)

Altman Z'' -4.05

(A) 0.03 = (Total Current Assets 1.01b - Total Current Liabilities 829.0m) / Total Assets 5.54b
(B) -0.51 = Retained Earnings (Balance) -2.83b / Total Assets 5.54b
(C) -0.26 = EBIT TTM -1.81b / Avg Total Assets 6.90b
(D) -0.79 = Book Value of Equity -2.79b / Total Liabilities 3.53b
Total Rating: -4.05 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 35.39

1. Piotroski 5.0pt
2. FCF Yield 8.30%
3. FCF Margin 10.62%
4. Debt/Equity 1.00
5. Debt/Ebitda -1.29
6. ROIC - WACC (= -45.98)%
7. RoE -63.17%
8. Rev. Trend -63.23%
9. EPS Trend -23.94%

What is the price of ALIT shares?

As of December 14, 2025, the stock is trading at USD 2.11 with a total of 7,344,952 shares traded.
Over the past week, the price has changed by +3.43%, over one month by -7.05%, over three months by -41.65% and over the past year by -69.51%.

Is ALIT a buy, sell or hold?

Alight has received a consensus analysts rating of 4.57. Therefore, it is recommended to buy ALIT.
  • Strong Buy: 5
  • Buy: 1
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the ALIT price?

Issuer Target Up/Down from current
Wallstreet Target Price 5.9 177.7%
Analysts Target Price 5.9 177.7%
ValueRay Target Price 1.5 -29.4%

ALIT Fundamental Data Overview December 09, 2025

Market Cap USD = 1.12b (1.12b USD * 1.0 USD.USD)
P/E Forward = 4.931
P/S = 0.4897
P/B = 0.5327
Beta = 1.126
Revenue TTM = 2.29b USD
EBIT TTM = -1.81b USD
EBITDA TTM = -1.40b USD
Long Term Debt = 1.99b USD (from longTermDebt, last quarter)
Short Term Debt = 20.0m USD (from shortTermDebt, last quarter)
Debt = 2.01b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.80b USD (from netDebt column, last quarter)
Enterprise Value = 2.93b USD (1.12b + Debt 2.01b - CCE 205.0m)
Interest Coverage Ratio = -20.57 (Ebit TTM -1.81b / Interest Expense TTM 88.0m)
FCF Yield = 8.30% (FCF TTM 243.0m / Enterprise Value 2.93b)
FCF Margin = 10.62% (FCF TTM 243.0m / Revenue TTM 2.29b)
Net Margin = -94.23% (Net Income TTM -2.16b / Revenue TTM 2.29b)
Gross Margin = 36.00% ((Revenue TTM 2.29b - Cost of Revenue TTM 1.47b) / Revenue TTM)
Gross Margin QoQ = 38.65% (prev 33.33%)
Tobins Q-Ratio = 0.53 (Enterprise Value 2.93b / Total Assets 5.54b)
Interest Expense / Debt = 1.19% (Interest Expense 24.0m / Debt 2.01b)
Taxrate = -23.10% (negative due to tax credits) (198.0m / -857.0m)
NOPAT = -2.23b (EBIT -1.81b * (1 - -23.10%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 1.21 (Total Current Assets 1.01b / Total Current Liabilities 829.0m)
Debt / Equity = 1.00 (Debt 2.01b / totalStockholderEquity, last quarter 2.00b)
Debt / EBITDA = -1.29 (negative EBITDA) (Net Debt 1.80b / EBITDA -1.40b)
Debt / FCF = 7.43 (Net Debt 1.80b / FCF TTM 243.0m)
Total Stockholder Equity = 3.41b (last 4 quarters mean from totalStockholderEquity)
RoA = -38.95% (Net Income -2.16b / Total Assets 5.54b)
RoE = -63.17% (Net Income TTM -2.16b / Total Stockholder Equity 3.41b)
RoCE = -33.49% (EBIT -1.81b / Capital Employed (Equity 3.41b + L.T.Debt 1.99b))
RoIC = -41.02% (negative operating profit) (NOPAT -2.23b / Invested Capital 5.43b)
WACC = 4.96% (E(1.12b)/V(3.13b) * Re(11.21%) + D(2.01b)/V(3.13b) * Rd(1.19%) * (1-Tc(-0.23)))
Discount Rate = 11.21% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 3.04%
[DCF Debug] Terminal Value 71.84% ; FCFE base≈207.0m ; Y1≈255.4m ; Y5≈435.7m
Fair Price DCF = 8.56 (DCF Value 4.47b / Shares Outstanding 522.8m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -23.94 | EPS CAGR: -2.11% | SUE: -0.11 | # QB: 0
Revenue Correlation: -63.23 | Revenue CAGR: -12.09% | SUE: -0.05 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.11 | Chg30d=+0.001 | Revisions Net=+0 | Analysts=6
EPS next Year (2026-12-31): EPS=0.59 | Chg30d=-0.039 | Revisions Net=-3 | Growth EPS=+5.7% | Growth Revenue=+1.7%

Additional Sources for ALIT Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle